| abstract |
The present disclosure relates to fused bicyclic compounds, their preparation methods and their applications in medicine. Specifically, the present disclosure relates to a fused bicyclic compound represented by the general formula (I), a preparation method thereof, a pharmaceutical composition containing the compound, and its use as a therapeutic agent, especially its use in the preparation of Use in drugs that inhibit HPK1. wherein each group in the general formula (I) is as defined in the specification. |